Exact Mass: 459.2192
Exact Mass Matches: 459.2192
Found 500 metabolites which its exact mass value is equals to given mass value 459.2192
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-[(1S,2S,4R)-2-Hydroxy-7,7-dimethyl-1-(spiro[indene-1,4'-piperidine]-1'-ylsulfonylmethyl)-2-bicyclo[2.2.1]heptanyl]acetic acid
2,5-Dihydroxy-1-octadec-9-enoyloxypyrrole-3-sulfonic acid
Methylcysteine sulfoxide
Methylcysteine sulfoxide is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). Methylcysteine sulfoxide can be found in soft-necked garlic, which makes methylcysteine sulfoxide a potential biomarker for the consumption of this food product.
Trifarotene
D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AD - Retinoids for topical use in acne C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D003879 - Dermatologic Agents
rel-(5aR,6R,12S,14aR)-12-[(1R)-1,2-dihydroxy-2-methylpropyl]-1,2,3,5a,6,11,12,14a-octahydro-5a-hydroxy-6,9-dimethoxy-5H,14H-pyrrolo[1,2:4,5]pyrazino[1,2:1,6]pyrido[3,4-b]indole-5,14-dione|rel-(8S,19S)-19,20-dihydro-9,19,20-trihydroxy-8-methoxy-9-epi-fumitremorgin C
Ile Asn Val Asp
Ala Glu Ile Gln
Ala Glu Leu Gln
Ala Glu Gln Ile
Ala Glu Gln Leu
Ala Ile Glu Gln
Ala Ile Gln Glu
Ala Leu Glu Gln
Ala Leu Gln Glu
Ala Asn Gln Gln
Ala Pro Ser Trp
Ala Pro Trp Ser
Ala Gln Glu Ile
Ala Gln Glu Leu
Ala Gln Ile Glu
Ala Gln Leu Glu
Ala Gln Asn Gln
Ala Gln Gln Asn
Ala Ser Pro Trp
Ala Ser Trp Pro
Ala Trp Pro Ser
Ala Trp Ser Pro
Cys Ile Pro Gln
Cys Ile Gln Pro
Cys Leu Pro Gln
Cys Leu Gln Pro
Cys Pro Ile Gln
Cys Pro Leu Gln
Cys Pro Gln Ile
Cys Pro Gln Leu
Cys Gln Ile Pro
Cys Gln Leu Pro
Cys Gln Pro Ile
Cys Gln Pro Leu
Asp Ile Asn Val
Asp Ile Val Asn
Asp Lys Pro Thr
Asp Lys Thr Pro
Asp Leu Asn Val
Asp Leu Val Asn
Asp Asn Ile Val
Asp Asn Leu Val
Asp Asn Val Ile
Asp Asn Val Leu
Asp Pro Lys Thr
Asp Pro Gln Thr
Asp Pro Thr Lys
Asp Pro Thr Gln
Asp Gln Pro Thr
Asp Gln Thr Pro
Asp Gln Val Val
Asp Thr Lys Pro
Asp Thr Pro Lys
Asp Thr Pro Gln
Asp Thr Gln Pro
Asp Val Ile Asn
Asp Val Leu Asn
Asp Val Asn Ile
Asp Val Asn Leu
Asp Val Gln Val
Asp Val Val Gln
Glu Ala Ile Gln
Glu Ala Leu Gln
Glu Ala Gln Ile
Glu Ala Gln Leu
Glu Ile Ala Gln
Glu Ile Gln Ala
Glu Lys Pro Ser
Glu Lys Ser Pro
Glu Leu Ala Gln
Glu Leu Gln Ala
Glu Asn Pro Thr
Glu Asn Thr Pro
Glu Asn Val Val
Glu Pro Lys Ser
Glu Pro Asn Thr
Glu Pro Gln Ser
Glu Pro Ser Lys
Glu Pro Ser Gln
Glu Pro Thr Asn
Glu Gln Ala Ile
Glu Gln Ala Leu
Glu Gln Ile Ala
Glu Gln Leu Ala
Glu Gln Pro Ser
Glu Gln Ser Pro
Glu Ser Lys Pro
Glu Ser Pro Lys
Glu Ser Pro Gln
Glu Ser Gln Pro
Glu Thr Asn Pro
Glu Thr Pro Asn
Glu Val Asn Val
Glu Val Val Asn
Gly Met Pro Arg
Gly Met Arg Pro
Gly Asn Asn Arg
Gly Asn Arg Asn
Gly Pro Met Arg
Gly Pro Arg Met
Gly Pro Thr Trp
Gly Pro Trp Thr
Gly Gln Gln Gln
Gly Arg Met Pro
Gly Arg Asn Asn
Gly Arg Pro Met
Gly Thr Pro Trp
Gly Thr Trp Pro
Gly Trp Pro Thr
Gly Trp Thr Pro
Ile Ala Glu Gln
Ile Ala Gln Glu
Ile Cys Pro Gln
Ile Cys Gln Pro
Ile Asp Asn Val
Ile Asp Val Asn
Ile Glu Ala Gln
Ile Glu Gln Ala
Ile Asn Asp Val
Ile Pro Cys Gln
Ile Pro Gln Cys
Ile Gln Ala Glu
Ile Gln Cys Pro
Ile Gln Glu Ala
Ile Gln Pro Cys
Ile Val Asp Asn
Ile Val Asn Asp
Lys Asp Pro Thr
Lys Asp Thr Pro
Lys Glu Pro Ser
Lys Glu Ser Pro
Lys Pro Asp Thr
Lys Pro Glu Ser
Lys Pro Ser Glu
Lys Pro Thr Asp
Lys Ser Glu Pro
Lys Ser Pro Glu
Lys Thr Asp Pro
Lys Thr Pro Asp
Leu Ala Glu Gln
Leu Ala Gln Glu
Leu Cys Pro Gln
Leu Cys Gln Pro
Leu Asp Asn Val
Leu Asp Val Asn
Leu Glu Ala Gln
Leu Glu Gln Ala
Leu Asn Asp Val
Leu Asn Val Asp
Leu Pro Cys Gln
Leu Pro Gln Cys
Leu Gln Ala Glu
Leu Gln Cys Pro
Leu Gln Glu Ala
Leu Gln Pro Cys
Leu Val Asp Asn
Leu Val Asn Asp
Met Gly Pro Arg
Met Gly Arg Pro
Met Asn Pro Val
Met Asn Val Pro
Met Pro Gly Arg
Met Pro Asn Val
Met Pro Arg Gly
Met Pro Val Asn
Met Arg Gly Pro
Met Arg Pro Gly
Met Val Asn Pro
Met Val Pro Asn
Asn Ala Gln Gln
Asn Asp Ile Val
Asn Asp Leu Val
Asn Asp Val Ile
Asn Asp Val Leu
Asn Glu Pro Thr
Asn Glu Thr Pro
Asn Glu Val Val
Asn Gly Asn Arg
Asn Gly Arg Asn
Asn Ile Asp Val
Asn Ile Val Asp
Asn Leu Asp Val
Asn Leu Val Asp
Asn Met Pro Val
Asn Met Val Pro
Asn Asn Gly Arg
Asn Asn Asn Val
Asn Asn Arg Gly
Asn Asn Val Asn
Asn Pro Glu Thr
Asn Pro Met Val
Asn Pro Thr Glu
Asn Pro Val Met
Asn Gln Ala Gln
Asn Gln Gln Ala
Asn Arg Gly Asn
Asn Arg Asn Gly
Asn Thr Glu Pro
Asn Thr Pro Glu
Asn Val Asp Ile
Asn Val Asp Leu
Asn Val Glu Val
Asn Val Ile Asp
Asn Val Leu Asp
Asn Val Met Pro
Asn Val Asn Asn
Asn Val Pro Met
Asn Val Val Glu
Pro Ala Ser Trp
Pro Ala Trp Ser
Pro Cys Ile Gln
Pro Cys Leu Gln
Pro Cys Gln Ile
Pro Cys Gln Leu
Pro Asp Lys Thr
Pro Asp Gln Thr
Pro Asp Thr Lys
Pro Asp Thr Gln
Pro Glu Lys Ser
Pro Glu Asn Thr
Pro Glu Gln Ser
Pro Glu Ser Lys
Pro Glu Ser Gln
Pro Glu Thr Asn
Pro Gly Met Arg
Pro Gly Arg Met
Pro Gly Thr Trp
Pro Gly Trp Thr
Pro Ile Cys Gln
Pro Ile Gln Cys
Pro Lys Asp Thr
Pro Lys Glu Ser
Pro Lys Ser Glu
Pro Lys Thr Asp
Pro Leu Cys Gln
Pro Leu Gln Cys
Pro Met Gly Arg
Pro Met Asn Val
Pro Met Arg Gly
Pro Met Val Asn
Pro Asn Glu Thr
Pro Asn Met Val
Pro Asn Thr Glu
Pro Asn Val Met
Pro Gln Cys Ile
Pro Gln Cys Leu
Pro Gln Asp Thr
Pro Gln Glu Ser
Pro Gln Ile Cys
Pro Gln Leu Cys
Pro Gln Ser Glu
Pro Gln Thr Asp
Pro Arg Gly Met
Pro Arg Met Gly
Pro Ser Ala Trp
Pro Ser Glu Lys
Pro Ser Glu Gln
Pro Ser Lys Glu
Pro Ser Gln Glu
Pro Ser Trp Ala
Pro Thr Asp Lys
Pro Thr Asp Gln
Pro Thr Glu Asn
Pro Thr Gly Trp
Pro Thr Lys Asp
Pro Thr Trp Gly
Pro Val Met Asn
Pro Val Asn Met
Pro Trp Ala Ser
Pro Trp Gly Thr
Pro Trp Ser Ala
Pro Trp Thr Gly
Gln Ala Glu Ile
Gln Ala Glu Leu
Gln Ala Ile Glu
Gln Ala Leu Glu
Gln Ala Asn Gln
Gln Ala Gln Asn
Gln Cys Ile Pro
Gln Cys Leu Pro
Gln Cys Pro Ile
Gln Cys Pro Leu
Gln Asp Val Val
Gln Glu Ala Ile
Gln Glu Ala Leu
Gln Glu Ile Ala
Gln Glu Leu Ala
Gln Gly Gln Gln
Gln Ile Ala Glu
Gln Ile Cys Pro
Gln Ile Glu Ala
Gln Ile Pro Cys
Gln Leu Ala Glu
Gln Leu Cys Pro
Gln Leu Glu Ala
Gln Leu Pro Cys
Gln Asn Ala Gln
Gln Asn Gln Ala
Gln Pro Cys Ile
Gln Pro Cys Leu
Gln Pro Ile Cys
Gln Pro Leu Cys
Gln Gln Ala Asn
Gln Gln Gly Gln
Gln Gln Asn Ala
Gln Gln Gln Gly
Gln Val Asp Val
Gln Val Val Asp
Arg Gly Met Pro
Arg Gly Asn Asn
Arg Gly Pro Met
Arg Met Gly Pro
Arg Met Pro Gly
Arg Asn Gly Asn
Arg Asn Asn Gly
Arg Pro Gly Met
Arg Pro Met Gly
Ser Ala Pro Trp
Ser Ala Trp Pro
Ser Glu Lys Pro
Ser Glu Pro Lys
Ser Lys Glu Pro
Ser Lys Pro Glu
Ser Pro Ala Trp
Ser Pro Glu Lys
Ser Pro Lys Glu
Ser Pro Trp Ala
Ser Trp Ala Pro
Ser Trp Pro Ala
Thr Asp Lys Pro
Thr Asp Pro Lys
Thr Gly Pro Trp
Thr Gly Trp Pro
Thr Lys Asp Pro
Thr Lys Pro Asp
Thr Pro Asp Lys
Thr Pro Gly Trp
Thr Pro Lys Asp
Thr Pro Trp Gly
Thr Trp Gly Pro
Thr Trp Pro Gly
Val Asp Ile Asn
Val Asp Leu Asn
Val Asp Asn Ile
Val Asp Asn Leu
Val Asp Gln Val
Val Asp Val Gln
Val Glu Asn Val
Val Glu Val Asn
Val Ile Asp Asn
Val Ile Asn Asp
Val Leu Asp Asn
Val Leu Asn Asp
Val Met Asn Pro
Val Met Pro Asn
Val Asn Asp Ile
Val Asn Asp Leu
Val Asn Glu Val
Val Asn Ile Asp
Val Asn Leu Asp
Val Asn Met Pro
Val Asn Asn Asn
Val Asn Pro Met
Val Asn Val Glu
Val Pro Met Asn
Val Pro Asn Met
Val Gln Asp Val
Val Gln Val Asp
Val Val Asp Gln
Val Val Glu Asn
Val Val Asn Glu
Val Val Gln Asp
Trp Ala Pro Ser
Trp Ala Ser Pro
Trp Gly Pro Thr
Trp Gly Thr Pro
Trp Pro Ala Ser
Trp Pro Gly Thr
Trp Pro Ser Ala
Trp Pro Thr Gly
Trp Ser Ala Pro
Trp Ser Pro Ala
Trp Thr Gly Pro
Trp Thr Pro Gly
(3S,4S)-TERT-BUTYL 3-ETHOXY-4-(2-(3-(TRIFLUOROMETHYL)BENZAMIDO)ACETAMIDO)PYRROLIDINE-1-CARBOXYLATE
Fluazacort
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
MK0731
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
Erk5-IN-1
ERK5-IN-1 is a potent ERK5 inhibitor with an IC50 of 87±7 nM. ERK5-IN-1 also inhibits LRRK2[G2019S] with an IC50 of 26 nM.
(2E)-10-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}dec-2-enoic acid
9R-(3R-hydroxy-5R-O-(1H-indol-3-ylcarbonyl)-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-decenoic acid
N-[(5R,14R)-5-Amino-5,14-dimethyl-4-oxo-3-oxa-18-azatricyclo[15.3.1.1~7,11~]docosa-1(21),7(22),8,10,17,19-hexaen-19-YL]-N-methylmethanesulfonamide
4-{4-[2-(1A,7A-Dimethyl-4-oxy-octahydro-1-oxa-4-aza-cyclopropa[A]naphthalen-4-YL)-acetylamino]-phenylcarbamoyl}-butyric acid
Trifarotene
D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AD - Retinoids for topical use in acne C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D003879 - Dermatologic Agents
Tert-butyl 4-[(4-amino-3-quinolin-3-ylpyrazolo[3,4-d]pyrimidin-1-yl)methyl]piperidine-1-carboxylate
2,5-Dihydroxy-1-octadec-9-enoyloxypyrrole-3-sulfonic acid
N-[(1S,2R,3E,7S,9E,13S,15R,19R)-7,13-dihydroxy-1,4,10,19-tetramethyl-17,18-dioxo-16-oxabicyclo[13.2.2]nonadeca-3,5,9,11-tetraen-2-yl]-2-oxopropanamide
2-{[3-cyano-4-(methoxymethyl)-6-methyl-2-pyridinyl]oxy}-N-{[1-(2,6-dimethylphenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylene}acetohydrazide
1-[(4-fluorophenyl)methyl]-N-[4-(4-methyl-1-piperazinyl)phenyl]-2-oxo-3H-benzimidazole-5-carboxamide
(3R,4R)-3-[4-(hydroxymethyl)phenyl]-N-(3-methoxypropyl)-2-(5-methyl-2-pyridinyl)-1-oxo-3,4-dihydroisoquinoline-4-carboxamide
N-[[(2S,3R)-8-(2-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
1-(2,5-difluorophenyl)-3-[(2R,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]urea
2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]-N-(4-phenylphenyl)acetamide
N-[(2S,3S)-4-[[(2R)-1-hydroxypropan-2-yl]-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-methoxy-3-methylbutyl]-N-methylcyclopropanecarboxamide
1-(2,5-difluorophenyl)-3-[(2S,3R,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]urea
1-(2,5-difluorophenyl)-3-[(2S,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(2,5-difluorophenyl)-3-[(2S,3S,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(2-pyridin-3-ylacetyl)amino]oxan-2-yl]-N-(4-phenylphenyl)acetamide
N-[(2R,3S)-4-[[(2S)-1-hydroxypropan-2-yl]-[[4-(trifluoromethyl)phenyl]carbamoyl]amino]-2-methoxy-3-methylbutyl]-N-methylcyclopropanecarboxamide
N-[(2R,3S)-4-[[(2R)-1-hydroxypropan-2-yl]-[[4-(trifluoromethyl)phenyl]carbamoyl]amino]-2-methoxy-3-methylbutyl]-N-methylcyclopropanecarboxamide
(2R)-2-[(4R,5S)-4-methyl-5-[[methyl(pyridin-2-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2R)-2-[(4S,5S)-4-methyl-5-[[methyl(pyridin-2-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
N-[[(2R,3S)-8-(2-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(2R,3R)-8-(2-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(2S,3S)-8-(2-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(2R,3R)-8-(2-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(2S,3R)-8-(2-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
1-(2,5-difluorophenyl)-3-[(2R,3S,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(2,5-difluorophenyl)-3-[(2R,3R,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]-N-(4-phenylphenyl)acetamide
N-[(2S,3R)-4-[[(2R)-1-hydroxypropan-2-yl]-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-methoxy-3-methylbutyl]-N-methylcyclopropanecarboxamide
N-[(2S,3S)-4-[[(2S)-1-hydroxypropan-2-yl]-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-methoxy-3-methylbutyl]-N-methylcyclopropanecarboxamide
N-(3,4-dimethylphenyl)-2-(2-ethoxy-4-{(E)-[2-(phenylacetyl)hydrazinylidene]methyl}phenoxy)acetamide
(2R)-2-[(4R,5R)-4-methyl-5-[[methyl(pyridin-2-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2S)-2-[(4S,5S)-4-methyl-5-[[methyl(pyridin-2-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2S)-2-[(4R,5S)-4-methyl-5-[[methyl(pyridin-2-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2S)-2-[(4R,5R)-4-methyl-5-[[methyl(pyridin-2-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2R)-2-[(4S,5R)-4-methyl-5-[[methyl(pyridin-2-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2S)-2-[(4S,5R)-4-methyl-5-[[methyl(pyridin-2-ylmethyl)amino]methyl]-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
N-[[(2S,3S)-8-(2-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
N-[[(2R,3S)-8-(2-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-2-methoxy-N-methylacetamide
(2S)-2-[(4S,5S)-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-(3-pyridinyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(3,3,3-trifluoropropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
1-(2,5-difluorophenyl)-3-[(2S,3S,6S)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(2,5-difluorophenyl)-3-[(2R,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]urea
2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]-N-(4-phenylphenyl)acetamide
2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]-N-(4-phenylphenyl)acetamide
N-[(2R,3R)-4-[[(2S)-1-hydroxypropan-2-yl]-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-methoxy-3-methylbutyl]-N-methylcyclopropanecarboxamide
N-[(2S,3R)-4-[[(2S)-1-hydroxypropan-2-yl]-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-methoxy-3-methylbutyl]-N-methylcyclopropanecarboxamide
1-[(1R)-1-benzoyl-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-cyclopropylethanone
1-[(1S)-1-benzoyl-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-cyclopropylethanone
IDH1 Inhibitor 7
IDH1 Inhibitor 7 (Compound 88) is an IDH1 inhibitor with an IC50 of less than 100 nM[1].